High specificity is important for an ovarian cancer test because this cancer is a relatively rare disease, occurring only in about 1 of 2500 postmenopausal women.

The ovarian cancer diagnostic test is being developed and tested first among women at risk of recurrence for ovarian cancer. If this use is successful, the test will next be extended to women at high risk for developing the disease.